Indici bursieri Piețe bursiere Simboluri Statistici

Simbol DVAX
Dynavax Technologies Corp.

miercuri, 24 iulie 2024, ora 17:58:13 EEST (UTC + 3)

Simbol DVAX
Simbol DVAX
Simbol eToro DVAX
MarketWatch DVAX
Finviz DVAX
Yahoo Finance DVAX
Google Finance DVAX
TradingView DVAX
Investing.com DVAX
Denumire Dynavax Technologies Corp.
Website dynavax.com
Piața NASDAQ
ISIN US2681582019
Sector Health Technology
Industrie Biotechnology
Monedă USD
Preț 13,6400 USD
Capitalizare bursieră 1,760 mld. USD
P/E 35,53
Beta 1,4443
EPS 0,3839
Profit anual +24,91%
Dată actualizare 18.12.2023


Descriere
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.


Istoric cotații

Data P/E Beta Capitalizare Dividend EPS Profit anual Preț
23.09.2021 0,00 1,0783 2,160 0,00% -0,2664 +313,25% $0,00
28.04.2023 5,29 1,3733 1,330 0,00% 1,9677 +11,25% $10,41
23.06.2023 8,31 1,4237 1,670 0,00% 1,5612 +3,70% $12,98
20.11.2023 35,63 1,4301 1,770 0,00% 0,3839 +7,05% $13,68
18.12.2023 35,53 1,4443 1,760 0,00% 0,3839 +24,91% $13,64



Pagină vizualizată de 85 ori și generată în 0,021462 secunde.